- Home
- ADAP vs BDL Comparison
ADAP vs BDL Comparison
Compare ADAP & BDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAP
- BDL
- Stock Information
- Founded
- ADAP 2008
- BDL 1959
- Country
- ADAP United Kingdom
- BDL United States
- Employees
- ADAP N/A
- BDL N/A
- Industry
- ADAP Biotechnology: Pharmaceutical Preparations
- BDL Restaurants
- Sector
- ADAP Health Care
- BDL Consumer Discretionary
- Exchange
- ADAP Nasdaq
- BDL Nasdaq
- Market Cap
- ADAP 75.5M
- BDL 60.8M
- IPO Year
- ADAP 2015
- BDL N/A
- Fundamental
- Price
- ADAP $0.25
- BDL $30.70
- Analyst Decision
- ADAP Buy
- BDL
- Analyst Count
- ADAP 6
- BDL 0
- Target Price
- ADAP $1.52
- BDL N/A
- AVG Volume (30 Days)
- ADAP 595.5K
- BDL 2.9K
- Earning Date
- ADAP 08-11-2025
- BDL 08-12-2025
- Dividend Yield
- ADAP N/A
- BDL 1.79%
- EPS Growth
- ADAP N/A
- BDL 14.76
- EPS
- ADAP N/A
- BDL 2.18
- Revenue
- ADAP $179,639,000.00
- BDL $198,785,000.00
- Revenue This Year
- ADAP N/A
- BDL N/A
- Revenue Next Year
- ADAP $35.48
- BDL N/A
- P/E Ratio
- ADAP N/A
- BDL $14.09
- Revenue Growth
- ADAP 878.53
- BDL 9.31
- 52 Week Low
- ADAP $0.20
- BDL $22.61
- 52 Week High
- ADAP $1.48
- BDL $35.98
- Technical
- Relative Strength Index (RSI)
- ADAP 42.09
- BDL 62.09
- Support Level
- ADAP $0.24
- BDL $29.41
- Resistance Level
- ADAP $0.27
- BDL $35.98
- Average True Range (ATR)
- ADAP 0.02
- BDL 1.39
- MACD
- ADAP -0.00
- BDL -0.20
- Stochastic Oscillator
- ADAP 23.57
- BDL 33.08
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.
About BDL Flanigan's Enterprises Inc.
Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.